Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Bob Swift who wrote (2522)	4/22/1999 11:43:00 PM
From: Don Miller	Read Replies (1) \| Respond to of 10280

Thanks for the replies guys, that rumor was not my issue. I personally believe this company is a gold mine for any Pharm smart enough to buy it before the stock hits 225 to 275. It probably would be a Pharm that does not have racemet drug being replaced, otherwise they lose their own patent extension value. Or they buy SEPR and sell their expiring patent right. My issue was buying LEAPS that could be made worthless if my concern becomes real. I'm greedy. I want this sucker for us, but I did want to flush money buying LEAPS if they became worthless in a take over, merger or buy out!